TSP Capital Management Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Buy
+1,419,365
New +$12.7M 3.2% 14
2026
Q1
Hold
0
14
2025
Q4
Sell
-1,399,065
Closed -$10.5M 20
2025
Q3
$12.1M Buy
+1,399,065
New +$10.9M 3.25% 14
2025
Q2
Sell
-1,352,165
Closed -$8.95M 17
2025
Q1
$8.67M Sell
1,352,165
-6,400
-0.5% -$52.9K 2.85% 15
2024
Q4
$10.9M Buy
1,358,565
+7,700
+0.6% +$74.2K 3.71% 13
2024
Q3
$17.1M Sell
1,350,865
-26,260
-2% -$339K 5.28% 4
2024
Q2
$17.4M Buy
1,377,125
+175
+0% +$1.76K 5.47% 3
2024
Q1
$6.58M Buy
1,376,950
+265,250
+24% +$1.23M 2.12% 18
2023
Q4
$5.34M Buy
1,111,700
+145,350
+15% +$890K 1.85% 20
2023
Q3
$7M Buy
966,350
+598,600
+163% +$4.78M 2.7% 18
2023
Q2
$2.73M Buy
367,750
+130,000
+55% +$1.02M 0.99% 28
2023
Q1
$1.65M Buy
237,750
+221,725
+1,384% +$2.04M 0.6% 35
2022
Q4
$165K Buy
+16,025
New +$283K 0.06% 52
2022
Q3
Hold
0
48
2022
Q2
Hold
0
41
2022
Q1
Hold
0
38
2021
Q4
Hold
0
28
2021
Q3
Hold
0
27
2021
Q2
Sell
-23,525
Closed -$4.31M 26
2021
Q1
$4.26M Sell
23,525
-26,550
-53% -$5.29M 1.5% 24
2020
Q4
$5.58M Buy
+50,075
New +$5.32M 1.98% 21
2020
Q3
Hold
0
20
2020
Q2
Hold
0
19
2020
Q1
Hold
0
27
2019
Q4
Hold
0
49

Other funds holding NVAX

TSP Capital Management Group's NVAX Position: Q2 2026 in Review

TSP Capital Management Group opened a new position in Novavax (NVAX) in Q2 2026: 1,419,365 shares worth $13.4M. The stake represents 3.2% of the portfolio and ranks #14 among its holdings. This is a return to the name: TSP Capital Management Group previously reported a position in NVAX as recently as Q3 2025.

TSP Capital Management Group first reported a position in NVAX in Q4 2020 and has held it in 14 quarters since. The position peaked at $17.4M in Q2 2024. 64 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • TSP Capital Management Group held 1,419,365 shares of Novavax worth $13.4M as of Q2 2026.
  • Novavax was a new TSP Capital Management Group position in Q2 2026.
  • Novavax made up 3.2% of TSP Capital Management Group's portfolio in Q2 2026, its #14 holding.
  • TSP Capital Management Group first reported a position in Novavax in Q4 2020 and has held it in 14 quarters since.
  • TSP Capital Management Group's Novavax position peaked at $17.4M in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on TSP Capital Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.